Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 253, Issue 3, 2015, Pages 335-342

  Hirota, Kazunari ^a   Keino, Hiroshi ^a   Inoue, Makoto ^a   Ishida, Hitoshi ^a   Hirakata, Akito ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Macular hole; microRNA; Proliferative diabetic retinopathy; Vitreous humor

Indexed keywords

MICRORNAS;

AGED; BLOOD; COMPARATIVE STUDY; DIABETIC RETINOPATHY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMANS; MALE; METABOLISM; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL PERFORATIONS; VITRECTOMY; VITREOUS BODY;

AGED; DIABETIC RETINOPATHY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL PERFORATIONS; VITRECTOMY; VITREOUS BODY;

EID: 84938764390     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-014-2692-5     Document Type: Article

References (28)

1. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS (2010) Non-coding RNAs: regulators of disease. J Pathol 220:126–139
2. Kanwar JR, Mahidhara G, Kanwar RK (2010) MicroRNA in human cancer and chronic inflammatory diseases. Front Biosci 2:1113–1126
3. Tomankova T, Petrek M, Gallo J, Kriegova E (2011) MicroRNAs: emerging regulators of immune-mediated diseases. Scand J Immunol. doi:10.1111/j.1365-3083.2011.02650.x
4. Anand S (2013) A brief primer on microRNAs and their roles in angiogenesis. Vasc Cell 5:2
5. Boon RA (2012) MicroRNAs control vascular endothelial growth factor signaling. Circ Res 111:1388–1390
6. Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D, Musolino C (2012) Circulating microRNAs; new biomarkers in diagnosis, prognosis and treatment of cancer. Int J Oncol 41:1897–1912
7. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA (2011) MicroRNAs in body fluids–the mix of hormones and biomarkers. Nat Rev Clin Oncol 8:467–477
8. Ragusa M, Caltabiano R, Russo A, Puzzo A, Avitabile T, Longo A, Toro MD, Di Pietro C, Purrello M, Reibaldi M (2013) MicroRNAs in vitreous humor from patients with ocular diseases. Mol Vis 19:430–440
9. Tuo J, Shen D, Yang HH, Chan CC (2014) Distinct microRNA-155 expression in the vitreous of patients with primary vitreoretinal lymphoma and uveitis. Am J Ophthalmol 15:728–734
10. Fong DS, Aiello LP, Ferris FL 3rd, Klein R (2004) Diabetic retinopathy. Diabetes Care 27:2540–2553
11. Salam A, Mathew R, Sivaprasad S (2011) Treatment of proliferative diabetic retinopathy with anti-VEGF agents. Acta Opthalmol 89:405–411
12. Saint-Geniez M, Maharaj AS, Walshe TE, Tucker BA, Sekiyama E, Kurihara T, Darland DC, Young MJ, D’Amore PA (2008) VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. PLoS One 3:e3554. doi:10.1371/journal.pone.0003554
13. Schraermeyer U, Julien S (2013) Effects of bevacizumab in retina and choroid after intravitreal injection into monkey eyes. Expert Opin Biol Ther 13:157–167
14. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F, Vandesompele J (2009) A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10:R64. doi:10.1186/gb-2009-10-6-r64
15. Yin KJ, Olsen K, Hamblin M, Zhang J, Schwendeman SP, Chen YE (2012) Vascular endothelial cell-specific microRNA-15a inhibits angiogenesis in hindlimb ischemia. J Biol Chem 287:27055–27064
16. Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, Hu RM (2009) MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol 36:181–188
17. Long J, Wang Y, Wang W, Chang BH, Danesh FR (2010) Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biol Chem 285:23457–23465
18. Fang JH, Zhou HC, Zeng C, Yang J, Liu Y, Huang X, Xhang JP, Guan XY, Zhuang SM (2011) MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology 54:1729–1740
19. Wu YY, Chen YL, Jao YC, Hsieh IS, Chang KC, Hong TM (2014) MiR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1. Angiogenesis 17:247–260
20. Liu LZ, Li C, Chen Q, Jing Y, Carpenter R, Jiang Y, Kung HF, Lai L, Jiang BH (2011) MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression. PLoS One 6:e19139. doi:10.1371/journal.pone.0019139
21. Zhao Y, Xu Y, Luo F, Xu W, Wang B, Pang Y, Zhou J, Wang X, Liu Q (2013) Angiogenesis, mediated by miR-21, is involved arsenite-induced carcinogenesis. Toxicol Lett 223:35–41
22. Li R, Chung AC, Yu X, Lan HY (2014) MicroRNAs in diabetic kidney disease. Int J Endocrinol 2014:593956
23. Zhong X, Chung AC, Chen HY, Dong Y, Meng XM, Li R, Yang W, Hou FF, Lan HY (2013) MiR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 56:663–674
24. Wang J, Gao Y, Ma M, Li M, Zou D, Yang J, Zhu Z, Zhao X (2013) Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice. Cell Biochem Biophys 67:537–546
25. Fiorentino L, Cavalera M, Mavilio M, Conserva F, Menghini R, Gesualdo L, Federici M (2013) Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs. Acta Diabetol 50:965–969
26. Zhong X, Chung AC, Chen HY, Meng XM, Lan HY (2011) Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 22:1668–1681
27. Guduric-Fuchs J, O’Connor A, Cullen A, Harwood L, Medina RJ, O’Neill CL, Stitt AW, Curtis TM, Simpson DA (2012) Deep sequencing reveals predominant expression of miR-21 amongst the small non-coding RNAs in retinal microvascular endothelial cells. J Cell Biochem 113:2098–2111
28. Zhou Q, Gallagher R, Ufret-Vincenty R, Li X, Olson EN, Wang S (2011) Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23 ∼ 27 ∼ 24 clusters. Proc Natl Acad Sci U S A 108:8287–8292